πŸ‡ΊπŸ‡Έ FDA
Patent

US 9226910

Treatment for obesity

granted A61KA61K31/27A61K9/0053

Quick answer

US patent 9226910 (Treatment for obesity) held by Jazz Pharmaceuticals International III Limited expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals International III Limited
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/27, A61K9/0053, A61K9/48, A61P